Tremeau to Exhibit at Upcoming Patient Conferences

Tremeau Pharmaceuticals will be exhibiting at the Coalition for Hemophilia B’s Annual Symposium in March in Orlando, FL and at HFA’s Annual Symposium in April in Baltimore, MD.

If you will be attending either conference, please stop by and visit us to learn about our upcoming Phase III clinical trial for TRM-201 (rofecoxib) for the treatment of Hemophilic Arthropathy.